The U.S. Senate will investigate the price of Novo Nordisk's popular weight loss and diabetes drugs Ozempic and Wegovy. Sen. Bernie Sanders asked Novo Nordisk's CEO in a letter how the price of ...
The Vermont senator is launching an investigation into why these game-changing diabetes and obesity drugs can cost… Senator ...
Novo Nordisk CEO Lars Fruergaard Jørgensen has agreed to voluntarily testify in September before the Senate’s health ...
In a letter to Bernie Sanders, Novo Nordisk said it only retains 60% of the list price of either Ozempic or Wegovy ...
After some persuasion from Sen. Bernie Sanders (I-Vt.), the CEO of Novo Nordisk will testify before lawmakers later this year ...
Senator Bernie Sanders launched a Senate investigation into the "outrageously high prices" of diabetes and weight loss drugs Ozempic and Wegovy made by Novo Nordisk. Sanders asked Novo Nordisk to ...
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor and Pensions (HELP) Committee, announced Tuesday he ...
Jorgensen’s decision was revealed in a statement from Senator Bernie Sanders (I-Vt), who had threatened to subpoena the ...
Novo Nordisk is contesting Sen. Bernie Sanders' calls to reduce the list prices of Ozempic and Wegovy in the U.S., Bloomberg reports. In late April, the Senate Health, Education, Labor, and ...
Click in for more news from The Hill{beacon} Health Care Health Care The Big Story Sanders drops subpoena threat against Novo Nordisk Sen. Bernie Sanders (I-Vt.), chairman of ...
(RTTNews) - Novo Nordisk (NVO) CEO Lars Fruergaard Jorgensen has agreed to testify before the Senate Health, Education, Labor and Pensions Committee, chaired by Senator Bernie Sanders, to defend the ...